MedTrace Logo

Efficacy and Safety of PEG 3350 for Treatment of Chronic Constipation

NCT03957668 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2020-10-20

No results posted yet for this study

Summary

The aim of this study is to determine the efficacy and safety of PEG 3350 (polyethylene glycol 3350) for short-term treatment of chronic constipation in adults.

Conditions

  • Constipation - Functional

Interventions

DRUG

PEG 3350

PEG 3350 17 g once daily for 14 days

DRUG

Lactulose

Lactulose 10 g once daily for 14 days

Sponsors & Collaborators

  • PT Meiji Indonesia

    collaborator UNKNOWN

  • Fakultas Kedokteran Universitas Indonesia

    lead OTHER

Principal Investigators

  • Murdani Abdulah · Fakultas Kedokteran Universitas Indonesia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-07
Primary Completion
2020-09-30
Completion
2020-10-31

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03957668 on ClinicalTrials.gov